Several other manufacturers recalled most of their heparin due to safety concerns in 2008. In close collaboration with the FDA, APP dramatically increased manufacturing capacity for heparin and assured healthcare professionals that the company would take every step necessary to meet supply needs of this life-saving drug.
Through significant investments in infrastructure and staffing, APP was able to provide a consistent supply
of Heparin Sodium to the U.S. market. Today, APP remains a reliable supplier of heparin to meet
patient needs.
References:
- IMS July 2010.
- Data on file, APP Pharmaceuticals, Schaumburg, IL. 2008.
® and APP® are registered trademarks of APP Pharmaceuticals, LLC.